샘플 요청 목록

 카트 문의
시장보고서
상품코드
1760920

세계의 단백질체학 시장

Proteomics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 577 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

단백질체학 세계 시장은 2030년까지 667억 달러에 도달

2024년에 374억 달러로 추정되는 단백질체학 세계 시장은 분석 기간인 2024-2030년 CAGR 10.1%로 성장하여 2030년에는 667억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 시약은 CAGR 10.0%를 나타내고, 분석 기간 종료시에는 492억 달러에 이를 것으로 예측됩니다. 기기 부문의 성장률은 분석 기간중 CAGR 11.0%로 추정됩니다.

미국 시장은 추정 138억 달러, 중국은 CAGR 12.8%로 성장 예측

미국의 단백질체학 시장은 2024년에 138억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 65억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.8%로 예상됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 9.0%와 9.2%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.7%를 보일 전망입니다.

세계의 단백질체학 시장 동향과 촉진요인 정리

단백질체학은 단백질, 그 구조, 기능 및 생물학적 시스템 내에서의 상호작용에 대한 대규모 연구입니다. 단백질은 거의 모든 세포 과정에 필수적이기 때문에 단백질체학은 세포가 어떻게 기능하고 질병이 어떻게 발병하는지에 대한 중요한 통찰력을 제공합니다. 단백질체학에 사용되는 기술에는 질량 분석, 단백질 마이크로어레이, 단백질 식별 및 정량화, 단백질 변형 분석, 단백질 간 상호작용을 매핑하는 다양한 생물정보학 도구가 포함됩니다. 이러한 기술을 통해 과학자들은 프로테옴(생물, 조직, 세포에서 생산되는 전체 단백질)을 탐색할 수 있습니다. 서로 다른 조건에서 프로테옴을 비교함으로써 연구자들은 질병의 바이오마커를 식별하고, 질병의 메커니즘을 이해하며, 표적 치료법을 개발할 수 있습니다.

최근 단백질체학의 발전은 그 능력과 응용을 크게 향상시켰습니다. 고해상도 질량 분석과 첨단 생물정보학 도구는 단백질 식별 및 정량화의 정확성과 효율성을 향상시켰습니다. 차세대 시퀀싱 및 CRISPR 기술과 같은 혁신은 단백질체학와 유전체학 및 전사체학과의 통합을 촉진하여 세포 과정에 대한 보다 종합적인 이해를 제공합니다. 또한, 단일 세포 단백질체학의 개발은 세포의 불균일성과 질병 진행을 전례 없는 해상도로 연구할 수 있는 새로운 길을 열어주고 있습니다. 이러한 기술의 발전은 프로테옴에 대한 보다 정밀하고 상세한 분석을 가능하게 함으로써 신약개발, 맞춤의료, 임상진단 등 다양한 분야에서 단백질체학의 활용을 촉진하고 있습니다.

단백질체학 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 암, 심혈관 질환과 같은 만성 질환의 유병률 증가로 인해 고급 진단 및 치료 솔루션에 대한 수요가 증가하고 있으며, 이는 단백질체학 도입에 박차를 가하고 있습니다. 또한, 개인별 단백질체학 프로파일을 이해하여 치료를 조정하는 개인 맞춤형 의료로의 전환도 큰 원동력이 되고 있습니다. 성장의 원동력으로는 많은 자가면역질환에 대한 단백질 표적치료제 및 정밀 분자 의약품 개발, 질량분석 기반 단백질체학 개발, 악성 종양의 분자 표적 개발 등을 들 수 있습니다. 새로운 단백질체학 응용 분야 발굴, 신약 개발, 심혈관 질환 및 암과 같은 다양한 유형의 질병에서 단백질체학 바이오마커 탐색을 위한 연구개발에 대한 생명공학 기업 및 제약 기업의 관심 증가는 세계 단백질체학 환경의 주요 트렌드입니다. 질량 분석과 바이오인포매틱스의 기술 발전으로 인해 프로테옴 분석의 기능이 강화되어 보다 쉽고 비용 효율적으로 이용할 수 있게 되었습니다. 또한, 바이오마커 발굴 및 의약품 개발 등의 분야에서의 연구 확대가 시장 개척에 박차를 가하고 있습니다. 정부 및 민간 기업의 연구 및 인프라 투자, 학계와 제약사의 협력도 시장 확대에 기여하고 있습니다. 이러한 요인에 더해, 단백질체학가 생명과학 연구의 중요한 도구로 인식되고 있는 것도 단백질체학 시장의 성장을 가속하고 있습니다.

부문

컴포넌트(시약, 기기, 서비스);용도(Drug Discovery, 질병 진단, 기타 용도)

조사 대상 기업 예(총 178개사)

  • Active Motif, Inc.
  • 20/20 Genesystems, Inc.
  • BG Medicine, Inc.
  • BGI-Shenzhen
  • Biodesix, Inc.
  • Abbiotec LLC
  • BioChain Institute, Inc.
  • Arbor Vita Corporation
  • Biomosaics, Inc.
  • Advansta Inc.
  • AYOXXA Biosystems GmbH
  • AKESOgen, Inc.
  • Biognosys
  • Biorbyt
  • BioAnalyte

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 중동
  • 아프리카

제4장 경쟁

LSH 25.07.08

Global Proteomics Market to Reach US$66.7 Billion by 2030

The global market for Proteomics estimated at US$37.4 Billion in the year 2024, is expected to reach US$66.7 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$49.2 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 11.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.8 Billion While China is Forecast to Grow at 12.8% CAGR

The Proteomics market in the U.S. is estimated at US$13.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global Proteomics Market - Key Trends & Drivers Summarized

Proteomics is the large-scale study of proteins, their structures, functions, and interactions within a biological system. As proteins are essential to nearly every cellular process, proteomics provides crucial insights into how cells function and how diseases develop. Techniques used in proteomics include mass spectrometry, protein microarrays, and various bioinformatics tools to identify and quantify proteins, analyze protein modifications, and map protein-protein interactions. These techniques allow scientists to explore the proteome, the entire set of proteins produced by an organism, tissue, or cell. By comparing proteomes under different conditions, researchers can identify disease biomarkers, understand disease mechanisms, and develop targeted therapies, making proteomics indispensable in biomedical research.

Recent advancements in proteomics have significantly enhanced its capabilities and applications. High-resolution mass spectrometry and advanced bioinformatics tools have improved the accuracy and efficiency of protein identification and quantification. Innovations such as next-generation sequencing and CRISPR technology have facilitated the integration of proteomics with genomics and transcriptomics, providing a more comprehensive understanding of cellular processes. Additionally, the development of single-cell proteomics is opening new avenues for studying cellular heterogeneity and disease progression at an unprecedented resolution. These technological advancements are driving the adoption of proteomics in various fields, including drug discovery, personalized medicine, and clinical diagnostics, as they enable more precise and detailed analysis of the proteome.

The growth in the proteomics market is driven by several factors. The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases has heightened the demand for advanced diagnostic and therapeutic solutions, spurring the adoption of proteomics. The shift towards personalized medicine, which relies on understanding individual proteomic profiles to tailor treatments, is also a significant driver. Factors supporting growth also include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Technological advancements in mass spectrometry and bioinformatics are enhancing the capabilities of proteomic analysis, making it more accessible and cost-effective. Furthermore, the expansion of research in areas such as biomarker discovery and drug development is fueling market growth. Government and private sector investments in proteomics research and infrastructure, coupled with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market's expansion. These factors, along with the growing recognition of proteomics as a critical tool in life sciences research, are propelling the growth of the proteomics market.

SCOPE OF STUDY:

The report analyzes the Proteomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents, Instruments, Services); Application (Drug Discovery, Disease Diagnosis, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 178 Featured) -

  • Active Motif, Inc.
  • 20/20 Genesystems, Inc.
  • BG Medicine, Inc.
  • BGI-Shenzhen
  • Biodesix, Inc.
  • Abbiotec LLC
  • BioChain Institute, Inc.
  • Arbor Vita Corporation
  • Biomosaics, Inc.
  • Advansta Inc.
  • AYOXXA Biosystems GmbH
  • AKESOgen, Inc.
  • Biognosys
  • Biorbyt
  • BioAnalyte

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Proteomics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Proteins, Proteome and Proteomics: A Prelude
    • Genesis of Proteomics
    • Important Milestones
    • An Insight into Proteomics Data Type and their Characteristics / Features
    • Proteomics and Genomics: A Comparison
    • Applications of Proteomics
    • Outlook
    • Proteomics at the Fore with Latest Advances
    • Regional Analysis
    • Key Challenges to Address
    • Sparse and Difficult to Measure Data
    • Democratizing Proteomics
    • Absence of High-Profile Projects for Stimulating Interest
    • Creating Novel Experimental Design
    • Lack of Commercialization of High Throughput Impacts
    • Lack of Necessary Technical Skillset
    • Competition
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Proteomics Profiling to Expedite Drug Discovery
    • Other Applications of Proteomics in Drug Discovery
    • New Proteomics Technique to Aid Drug Screening & Biomarker Discovery
    • Growing Interest in Personalized Medicine to Drive Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Oncology: A Key Focus Area for Proteomics
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Proteomic Approaches Gain Prominence in Cancer Drug Discovery
    • Proteomics Technologies Used in Cancer Drug Discovery and Development
    • Role of Proteomics in Oncology Biomarker Discovery
    • List of FDA-approved Protein Biomarkers for Cancer
    • Advancements in Proteomics Bring Biomarkers into Limelight
    • Different Types of MS-Based Proteomic Discovery Techniques for Biomarkers
    • Affinity-Reagent-Array-Based Techniques
    • Affinity-and-Antibody-Based MS Techniques
    • CE-MS Technology: An Emerging Technology for Discovery of Biomarkers
    • Protein Microarrays: A Novel Tool for the Development of Pharmaceuticals
    • Protein Microarray Formats
    • New Technologies Expand Application of Proteomics
    • DIA Technique for Protein Discovery
    • AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns
    • Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction
    • Single-Cell Proteomics Offers a Better Understanding of Cellular Identity
    • Metalloproteomics: A Rapidly Evolving Field
    • Post-translational Modification of Proteins Increases Functional Diversity of Proteome
    • Pharmacoproteomics Holds Significant Prospects in Precision Medicine
    • Increasing Prominence of Nanoproteomics Widens Opportunities
    • Global Proteomics Sample Preparation Market
    • Challenges Faced
    • Management of Data in Proteomics Research Poses a Big challenge
    • Role of Contract Research Organizations to Increase in Proteomics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Proteomics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 137: Middle East Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Middle East Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Middle East 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 140: Middle East Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Middle East Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Middle East 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 143: Africa Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Africa Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Africa 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2015, 2025 & 2030
    • TABLE 146: Africa Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Africa Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Africa 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제